Veena Venugopalan

PRG DIR & CLIN PROF

PH PHARMACY EDUCATION AND PRAC

  • PRG DIR & CLIN PROF
    PH PHARMACY EDUCATION AND PRAC

GRANTS

  • GRANT
    Real-World, Multicenter Experience with Ceftolozane/Tazobactam (C/T) in the Pediatric Population
    Merck Sharp & Dohme22 Jan 2026 - 21 Jan 2029
    Active
  • GRANT
    Ceftazidime-Avibactam versus Meropenem-Vaborbactam for the treatment of bloodstream infections and/or pneumonia due to carbapenem-resistant EnterobacteraLes
    Melinta Therapeutics16 Jul 2025 - 30 Nov 2026
    Active
  • GRANT
    Real World Multicenter Observational Study of Imipenem-CilastatinRelebactam for Gram-Negative Infections
    Merck and Company Inc10 Oct 2024 - 27 Oct 2025
    Expired
  • GRANT
    Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal ß-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS)
    Merck Sharp & Dohme4 Sep 2024 - 5 Sep 2024
    Closed
  • GRANT
    Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal ß-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS)
    Merck Sharp & Dohme4 Sep 2024 - 12 Dec 2027
    Active
  • GRANT
    Cefiderocol treatment Versus ceftolozane/tazobactam for the treatment of pneumonia and/or bloodstream Infections due to multidrug-resistant Pseudomonas aeruginosa (CONVINCE)
    Shionogi Inc2 Apr 2024 - 1 Apr 2027
    Active
  • GRANT
    Ceftazidime-Avibactam Contemporary Use and Evaluation of Time to Appropriate Therapy for Gram-Negative infections: A Multicenter Observational Study
    Abbvie20 Jul 2023 - 19 Jul 2026
    Expired
  • GRANT
    A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)
    Merck Sharp & Dohme2 Nov 2022 - 3 Feb 2024
    Closed
  • GRANT
    UF and FDOH Collaboration for "Nursing Home and Long Term Care Facility Strike Team and Infrastructure Project"
    Centers for Disease Control and Prevention12 Oct 2022 - 30 Jun 2024
    Expired
  • GRANT
    Beta-lactam continuous vs intermittent infusion and associated bacterial resistance and therapy outcomes in critically ill patients with severe pneumonia
    US Food and Drug Administration28 Sep 2021 - 28 Feb 2023
    Expired
  • GRANT
    Prevalence of Cefazolin Inoculum Effect in Mcthicillin Susceptible Staphylococcus aureus Bacteremia
    UF Health Shands Hospital16 Apr 2021 - 1 Jul 2024
    Expired
  • GRANT
    Developing a Virtual Tour of the Microbiology Lab
    Society of Infectious Diseases Pharmacists6 Apr 2021 - 14 Mar 2022
    Expired
  • GRANT
    Effect of Subinhibitory Concentrations of Linezolid, Tedizolid, Clindamycin, and Vancomycin on Staphylokinase Production by Community-Associated Methicillin-Resistant Staphylococcus aureus and its Potential Implication on Influenza A/Staphylococcus aureus
    UF Health Shands Hospital3 Mar 2017 - 30 Jun 2019
    Expired